List of insiders holdings for Axonics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Wisniewski Raphael Director 10% Owner | 2020-01-22 21:19:58 | 0 2,957,461 | 2,957,461 | Form 4 |
| 2 | Petrovich John George Director | 2018-12-10 21:13:03 | 7,500 2,102,970 | 2,110,470 | Form 4 |
| 3 | Andera Partners BioDiscovery 4 FCPR 10% Owner | 2021-02-03 07:11:31 | 1,987,282 0 | 1,987,282 | Form 13D |
| 4 | Longitude Capital Partners III LLC ENRIGHT PATRICK G Longitude Venture Partners III L.P. 10% Owner | 2021-01-26 17:19:56 | 1,974,692 0 | 1,974,692 | Form 13D |
| 5 | Tammenoms Bakker Juliet Director | 2020-09-22 18:01:42 | 3,500 1,956,359 | 1,959,859 | Form 4 |
| 6 | Malik Shahzad Director | 2018-12-10 21:12:09 | 7,500 1,694,349 | 1,701,849 | Form 4 |
| 7 | Alfred E. Mann Foundation for Scientific Research Former 10% Owner | 2021-04-08 16:32:28 | 1,602,970 0 | 1,602,970 | Form 13G |
| 8 | Amble Erik Director | 2020-08-26 20:17:38 | 12,667 1,520,884 | 1,533,551 | Form 4 |
| 9 | NeoMed Innovation V Ltd NeoMed Innovation V L.P. Former 10% Owner | 2018-11-02 19:51:37 | 0 1,520,884 | 1,520,884 | Form 4 |
| 10 | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Chen Bihua 10% Owner | 2018-11-09 16:07:02 | 1,285,827 0 | 1,285,827 | Form 13G |
| 11 | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare GP LLC Cormorant Global Healthcare Master Fund LP 10% Owner | 2018-11-09 16:07:02 | 1,285,827 0 | 1,285,827 | Form 13G |
| 12 | Advent Life Sciences LLP Advent Life Sciences Fund II LP Former 10% Owner | 2020-02-11 13:57:49 | 1,273,859 0 | 1,273,859 | Form 13G |
| 13 | Kuang Zhong Zac & Cloud Holdings LTD Former 10% Owner | 2018-11-02 19:26:26 | 0 884,853 | 884,853 | Form 4 |
| 14 | Williamson Michael V. SVP, General Counsel | 2019-07-02 21:30:14 | 152,318 0 | 152,318 | Form 4 |
| 15 | MATHUR PRABODH See Remarks | 2019-02-01 21:34:12 | 40,889 0 | 40,889 | Form 4 |
| 16 | Jiang Guangqiang Chief Technology Officer | 2019-02-01 21:39:44 | 40,889 0 | 40,889 | Form 4 |
| 17 | Dearen Danny L. President & CFO | 2023-10-03 19:37:17 | 23,777 0 | 23,777 | Form 4 |
| 18 | MCNAMARA ROBERT E Director | 2021-01-15 19:12:42 | 7,500 0 | 7,500 | Form 4 |
| 19 | Pardo Geoff Former 10% Owner | 2019-12-10 13:43:00 | 0 0 | 0 | Form 4 |
| 20 | Gilde Healthcare Holding B.V. Gilde Healthcare IV Management B.V. Cooperatieve Gilde Healthcare IV U.A. Former 10% Owner | 2022-06-06 06:06:59 | 0 0 | 0 | Form 13G |
| 21 | CARREL MICHAEL H Director | 2024-11-15 08:58:51 | 0 0 | 0 | Form 4 |
| 22 | COHEN RAYMOND W Chief Executive Officer | 2024-11-15 08:59:03 | 0 0 | 0 | Form 4 |
| 23 | Demski David M Director | 2024-11-15 08:59:11 | 0 0 | 0 | Form 4 |
| 24 | Ford Alfred J Jr Chief Commercial Officer | 2024-11-15 08:59:19 | 0 0 | 0 | Form 4 |
| 25 | Keese Kari Leigh Chief Financial Officer | 2024-11-15 08:59:28 | 0 0 | 0 | Form 4 |
| 26 | Lopez Esteban Director | 2024-11-15 08:59:36 | 0 0 | 0 | Form 4 |
| 27 | McNamara Robert Director | 2024-11-15 08:59:43 | 0 0 | 0 | Form 4 |
| 28 | Noblett Karen Chief Medical Officer | 2024-11-15 08:59:51 | 0 0 | 0 | Form 4 |
| 29 | Sama Rinda Chief Operating Officer | 2024-11-15 08:59:59 | 0 0 | 0 | Form 4 |
| 30 | snyderman nancy lynn MD Director | 2024-11-15 09:00:06 | 0 0 | 0 | Form 4 |
| 31 | Woock John EVP, Chief Mktg/Strtgy Officer | 2024-11-15 09:00:14 | 0 0 | 0 | Form 4 |
| 32 | Kiernan Jane E Director | 2024-11-15 09:00:20 | 0 0 | 0 | Form 4 |